GKSL Share Price | Gujarat Kidney & Super Speciality Ltd Stock Analysis & Recommendation

Q: What does Gujarat Kidney do?

Overview:Gujarat Kidney & Super Speciality Ltd operates in the hospital industry and is classified as a micro-cap company.History:The company was incorporated in 2019 under the name Vihaan Medicare Private Limited. It later changed its name to Gujarat Kidney and Super Speciality Private Limited, with the latest certificate of incorporation issued on September 13, 2023. The most recent quarterly results reported net sales and net profit for the period ending March 2026.Financial Snapshot:Net Sales: 31 Cr (Quarterly Results - Mar 2026) Net Profit: 5 Cr (Quarterly Results - Mar 2026) Market Cap: INR 1,016 Cr (Micro Cap)Key Metrics:P/E: 63.00 Industry P/E: 60 Dividend Yield: 0.00% Debt Equity: -0.11 Return on Equity: 6.14% Price to Book: 4.06 Contact Details:No Company Details Available Registrar Address: Not available.

Q: Who are the peers of the Gujarat Kidney?

Peers: The peers of Gujarat Kidney are Indrapr.Medical, Dr Agarwal's Eye, KMC Speciality, Shalby, GPT Healthcare, Asarfi Hospital, Lotus Eye Hospit, Unihealth Hosp, Chandan Healthca, and Aprameya Enginee.Quality Snapshot: Excellent management risk is observed at GPT Healthcare and Aprameya Enginee, while Average management risk is found at Indrapr.Medical, Dr Agarwal's Eye, KMC Speciality, Shalby, Asarfi Hospital, Unihealth Hosp, Chandan Healthca, and the rest. Below Average management risk is noted at Lotus Eye Hospit. For Growth, Excellent growth is seen at Dr Agarwal's Eye, Unihealth Hosp, and Chandan Healthca, while Good growth is found at KMC Speciality, Asarfi Hospital, and the rest. Below Average growth is observed at Shalby and Aprameya Enginee. For Capital Structure, Excellent capital structure is noted at KMC Speciality, GPT Healthcare, and Unihealth Hosp, while Good capital structure is found at Shalby, Asarfi Hospital, and Chandan Healthca, and the rest.Return Snapshot: KMC Speciality has the highest 1-year return at 75.31%, while Indrapr.Medical has the lowest at -9.19%. Gujarat Kidney's 1-year return is not available for comparison. Additionally, the six-month return is negative for Indrapr.Medical, Shalby, and GPT Healthcare.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.01 lacs (-33.50%) Volume

Shareholding (Mar 2026)

FII

4.88%

Held by 12 FIIs

DII

0.56%

Held by 0 DIIs

Promoter

71.45%

Why is Gujarat Kidney & Super Speciality Ltd falling/rising?

23-Jun-2026

As of 22-Jun, Gujarat Kidney & Super Speciality Ltd's stock price is currently at 128.90, reflecting a recent upward trend despite declines over the past week and month. Year-to-date, the stock has grown by 25.45%, contrasting with the Sensex's decline, although decreased investor participation may affect future price movements.

View full answer

Which are the latest news on Gujarat Kidney?

23-Jun-2026

Gujarat Kidney & Super Speciality Ltd Shows Mildly Bullish Momentum Amid Mixed Returns
Gujarat Kidney & Super Speciality Ltd is Rated Hold

What does Gujarat Kidney do?

11-Jun-2026

Gujarat Kidney & Super Speciality Ltd, a micro-cap company incorporated in 2019, operates in the hospital industry and reported net sales of 31 Cr and a net profit of 5 Cr for the quarter ending March 2026. Key metrics include a P/E ratio of 63.00 and a market cap of INR 1,016 Cr.

View full answer

How big is Gujarat Kidney?

11-Jun-2026

As of 10th June, Gujarat Kidney & Super Speciality Ltd has a market capitalization of 1,016.00 Cr, with Net Sales of 82.02 Cr and a Net Profit of 15.49 Cr reported in the latest four quarters.

View full answer

Who are the peers of the Gujarat Kidney?

11-Jun-2026

Peers of Gujarat Kidney include Indrapr.Medical, Dr Agarwal's Eye, KMC Speciality, Shalby, and others. KMC Speciality leads in 1-year returns at 75.31%, while Indrapr.Medical has the lowest at -9.19%.

View full answer

Should I buy, sell or hold Gujarat Kidney & Super Speciality Ltd?

31-May-2026

When is the next results date for Gujarat Kidney & Super Speciality Ltd?

12-Feb-2026

The next results date for Gujarat Kidney & Super Speciality Ltd is 14 February 2026.

View full answer

Compare Gujarat Kidney with Similar Stocks

GPT Healthcare Unihealth Hosp Shalby

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.08 times

Healthy long term growth as Net Sales has grown by an annual rate of 0% and Operating profit at 0%

With a growth in Net Sales of 2.87%, the company declared Very Positive results in Mar 26

With ROE of 6.1, it has a Very Expensive valuation with a 4 Price to Book Value

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Hospital

Market cap

INR 1,004 Cr (Micro Cap)

P/E

66.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.11

Return on Equity

6.14%

Price to Book

4.04

Revenue and Profits:

Net Sales:

31 Cr

(Quarterly Results - Mar 2026)

Net Profit:

5 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

24.35%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Gujarat Kidney for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

Gujarat Kidney & Super Speciality Ltd Shows Mildly Bullish Momentum Amid Mixed Returns

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has exhibited a notable shift in technical momentum, moving from a sideways trend to a mildly bullish stance. Recent price action, combined with key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggests a cautiously optimistic outlook for the stock amid mixed market conditions.

Read full news article

Gujarat Kidney & Super Speciality Ltd is Rated Hold

Gujarat Kidney & Super Speciality Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 June 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Gujarat Kidney & Super Speciality Ltd Sees Technical Momentum Shift Amid Sideways Trend

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a year-to-date return of 25.06%, the stock’s recent price action and technical indicators suggest a period of consolidation, with mixed signals from key momentum oscillators and moving averages.

Read full news article

Announcements

Notice Of Postal Ballot

04-Jun-2026 | Source : BSE

Notice of Postal ballot

Announcement under Regulation 30 (LODR)-Newspaper Publication

04-Jun-2026 | Source : BSE

Newspaper Publication for Notice of Postal Ballot

Compliances-Reg.24(A)-Annual Secretarial Compliance

30-May-2026 | Source : BSE

Annual Secretarial Compliance Report for the year ended on March 31 2026

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

12.54

Debt to EBITDA (avg)

0.92

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.74

Tax Ratio

20.82%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

5.44%

ROCE (avg)

26.45%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.04

EV to EBIT

44.69

EV to EBITDA

36.89

EV to Capital Employed

4.41

EV to Sales

12.12

PEG Ratio

Dividend Yield

ROCE (Latest)

9.87%

ROE (Latest)

6.14%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

Bullish

KST

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 12 FIIs (4.88%)

Promoter with highest holding

Pragnesh Yashwantsinh Bharpoda (38.16%)

Highest Public shareholder

Khandelwal Finance Private Limited (1.67%)

Individual Investors Holdings

10.64%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -5.33% vs 1.24% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -41.20% vs 1.30% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.24",
          "val2": "9.76",
          "chgp": "-5.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.57",
          "val2": "4.14",
          "chgp": "-62.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.29",
          "chgp": "72.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.37",
          "val2": "2.33",
          "chgp": "-41.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.99%",
          "val2": "42.42%",
          "chgp": "-25.43%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "21.09",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.42",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.36",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "6.20",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "49.41%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.85",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.56",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.65",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.53",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "47.20%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "40.10",
          "val2": "35.17",
          "chgp": "14.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.14",
          "val2": "15.45",
          "chgp": "4.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.15",
          "val2": "0.53",
          "chgp": "116.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.90",
          "val2": "9.11",
          "chgp": "8.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.25%",
          "val2": "43.93%",
          "chgp": "-3.68%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

9.24

9.76

-5.33%

Operating Profit (PBDIT) excl Other Income

1.57

4.14

-62.08%

Interest

0.50

0.29

72.41%

Exceptional Items

0.00

Standalone Net Profit

1.37

2.33

-41.20%

Operating Profit Margin (Excl OI)

16.99%

42.42%

-25.43%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -5.33% vs 1.24% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is -41.20% vs 1.30% in Dec 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Change(%)

Net Sales

21.09

Operating Profit (PBDIT) excl Other Income

10.42

Interest

0.36

Exceptional Items

0.00

Standalone Net Profit

6.20

Operating Profit Margin (Excl OI)

49.41%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Change(%)

Net Sales

30.85

Operating Profit (PBDIT) excl Other Income

14.56

Interest

0.65

Exceptional Items

0.00

Standalone Net Profit

8.53

Operating Profit Margin (Excl OI)

47.20%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

40.10

35.17

14.02%

Operating Profit (PBDIT) excl Other Income

16.14

15.45

4.47%

Interest

1.15

0.53

116.98%

Exceptional Items

0.00

Standalone Net Profit

9.90

9.11

8.67%

Operating Profit Margin (Excl OI)

40.25%

43.93%

-3.68%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Gujarat Kidney & Super Speciality Ltd

Gujarat Kidney & Super Speciality Ltd

Micro Cap

Hospital

Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of `Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre. Subsequently, the Company name was changed to `Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.

Company Coordinates

No Company Details Available